Biohaven Ltd. SEC filings BHVN

Biohaven Ltd. has 282 filings in SEC EDGAR's recent list, going back to Jul 1, 2022. Its latest annual report, Form 10-K, was filed on Mar 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Biohaven Ltd. SEC filings
Form Description Filed Period
424B5 Prospectus supplement May 4, 2026 —
S-3ASR Automatic shelf registration May 4, 2026 —
S-8 Employee stock plan registration Mar 2, 2026 —
424B5 Prospectus supplement Nov 13, 2025 —
424B5 Prospectus supplement Nov 12, 2025 —
424B7 Filing Aug 15, 2025 —
424B5 Prospectus supplement Oct 1, 2024 —
424B5 Prospectus supplement Sep 30, 2024 —
424B7 Filing Aug 16, 2024 —
424B5 Prospectus supplement Aug 16, 2024 —
424B7 Filing May 17, 2024 —
S-8 Employee stock plan registration May 9, 2024 —
424B5 Prospectus supplement Apr 19, 2024 —
424B5 Prospectus supplement Apr 17, 2024 —
424B7 Filing Mar 12, 2024 —
424B5 Prospectus supplement Oct 4, 2023 —
424B5 Prospectus supplement Oct 2, 2023 —
424B5 Prospectus supplement Oct 2, 2023 —
S-3ASR Automatic shelf registration Oct 2, 2023 —
S-8 Employee stock plan registration May 12, 2023 —
424B4 Prospectus Oct 24, 2022 —
S-1MEF Filing Oct 20, 2022 —
S-1/A Amended registration statement Oct 20, 2022 —
S-1 Registration statement Oct 18, 2022 —
S-8 Employee stock plan registration Oct 11, 2022 —

Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BHVN (NYSE)
Fiscal year ends
December 31
Incorporated in
Virgin Islands, British
Headquarters
New Haven, CT
SEC filer status
Large accelerated filer
SEC CIK
1935979
Former names
Biohaven Research Ltd. (until Sep 14, 2022)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.